eLearning Series for Psychiatrists

The WFSBP offers two on-demand e-learning programmes developed for psychiatrists and mental health professionals. Both programmes provide expert-led educational content that can be accessed online at your own pace.

This series is designed for healthcare professionals, students, and anyone interested in mental health and offers in-depth insights into early intervention strategies for major mental disorders.

The modules are delivered in an engaging “TEDTalk” style format, featuring a mix of expert interviews, interactive quizzes, clinical scenarios, and patient testimonials. Each module is designed to provide 3 – 4 key learning takeaways, ensuring a comprehensive and impactful learning experience.

This educational series comprises three modules, each focusing on a different aspect of early intervention:

• Early Intervention: What is it and is it Effective?
• Early Intervention in Bipolar Disorder
• Early Interventions in Schizophrenia

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and World Federation of Societies of Biological Psychiatry (WFSBP). Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Amedco Joint Accreditation #4008163.

This innovative program aims to address clinicians’ questions on cognitive function in subjects at high risk for or suffering from bipolar disorder or schizophrenia.

By participating in this program, you will have the opportunity to listen to leading international experts discuss and share clinical insights on these important and highly relevant clinical topics.

This unique format consists of 14 online modules/topics accessed at your leisure from your home or office. The videos, presented in an informal conversational format, provide important scientific evidence on each topic. This program allows participants to test their knowledge and gain insights into the impact of cognitive impairment on the management of patients suffering from mental disorders, to optimize their care.

This program will help clinicians:

• Assess and monitor cognitive function in patients with bipolar disorder and schizophrenia
• Identify cognitive impairments in patients with bipolar disorder and schizophrenia
• Implement non-pharmacologic and pharmacologic interventions for the prevention and treatment of cognitive dysfunction in these patients